OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Cancer Research and Clinical Oncology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
A case of rare metachronous four primary carcinoma	163
Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”	123
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort	102
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients	88
Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas	80
Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy	78
Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case rep	77
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ	68
Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer	65
Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis	64
Systematic analysis of mistletoe prescriptions in clinical studies	64
Single-center experience in the diagnosis and treatment of lymphoepithelioma-like hepatic carcinoma	59
Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma	58
Combination of multiple nucleic acid aptamers for precision detection of tumors based on optical methods	58
Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection	53
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors	51
A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection	50
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cance	49
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study	47
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis	44
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma	44
Relevance of tumor boards for the inclusion of patients in oncological clinical trials	43
Breast cancer prediction using different machine learning methods applying multi factors	43
Comparison of robotic‑assisted versus conventional laparoscopic surgery for mid–low rectal cancer: a systematic review and meta-analysis	42
Optical coherence tomography and convolutional neural networks can differentiate colorectal liver metastases from liver parenchyma ex vivo	41

Oral microbiota may predict the presence of esophageal squamous cell carcinoma	41
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC	40
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells	40
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma	39
Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry	38
Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany	37
Prognostic nomogram for external ear melanoma patients in the elderly: a SEER-based study	37
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies	35
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma	35
The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours	34
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3	34